Full Length Research Paper
References
|
Abhilash KP, Mathiyalagan P, Krishnaraj VRK, Selvan S, Kanagarajan R, Reddy NP, Rajendiran N, Hazra D, Gunasekaran K, Moorthy M, Jasmine S, Davis JP, George T, George K, Varghese GM, Rupali P, Barney Isaac TJ, Gupta R, Pichamuthu K, Peter JV (2022). Impact of prior vaccination with CovishieldTM and Covaxin on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study. Vaccine 40(13):2107-2113. |
|
|
Albitar O, Ballouze R, Ping J, Maisharah S, Ghadzi S (2020). Risk factors for mortality among COVID-19 patients Orwa. Diabetes Research and Clinical Practice 166 (January):108293. |
|
|
Alexopoulos EC (2010). Introduction to multivariate regression analysis. Hippokratia 14(Suppl 1):23-28. |
|
|
Austin P (2011). An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behavioral Research 46(3):399-424. |
|
|
Ayaz A, Arshad A, Malik H, Ali H, Hussain E, Jamil B (2020). Risk factors for intensive care unit admission and mortality in hospitalized COVID-19 patients. Acute and Critical Care 35(4):249-254. |
|
|
Banholzer N, van Weenen E, Lison A, Cenedese A, Seeliger A, Kratzwald B, Tschernutter D, Salles JP, Bottrighi P, Lehtinen S, Feuerriegel S, Vach W (2021). Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave. PloS One 16(6):e0252827. |
|
|
Behera P, Singh AK, Subba SH, Mc A, Sahu DP, Chandanshive PD, Pradhan SK, Parida SP, Mishra A, Patro BK, and Batmanabane G (2022). Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India. Human Vaccines and Immunotherapeutics 18(1):2034456. |
|
|
Bell S, Campbell J, Lambourg E, Watters C, O'Neil M, Almond A, Mark PB (2022). The impact of vaccination on incidence and outcomes of SARS-CoV-2 infection in patients with kidney failure in Scotland. Journal of the American Society of Nephrology 33(4):677-686. |
|
|
Bennett KE, Mullooly M, O'Loughlin M, Fitzgerald M, O'Donnell J, O'Connor L, Oza A, and Cuddihy J (2021). Underlying conditions and risk of hospitalization, ICU admission and mortality among those with COVID-19 in Ireland: A national surveillance study. The Lancet Regional Health - Europe 5:100097. |
|
|
Campbell A, Caul S (2020). Deaths involving COVID-19. England and Wales: deaths occurring in June 2020. |
|
|
Chandrashekar A, Yu J, McMahan K, Jacob-Dolan C, Liu J, He X, Hope D, Anioke T, Barrett J, Chung B, Hachmann NP, Lifton M, Miller J, Powers O, Sciacca M, Sellers D, Siamatu M, Surve N, VanWyk H, Barouch DH (2022). Vaccine protection against the SARS-CoV-2 Omicron variant in macaques. Cell 185(9):1549-1555.e11. |
|
|
Chen H, Kwong JC, Copes R, Villeneuve PJ, Goldberg MS, Ally SL, Weichenthal S, van Donkelaar A, Jerrett M, Martin RV, Brook JR, Kopp A, Burnett RT (2017). Cohort Profile: The ONtario Population Health and Environment Cohort (ONPHEC). International Journal of Epidemiology 46(2):405-405. |
|
|
Cook TM, Roberts JV (2021). Impact of vaccination by priority group on UK deaths, hospital admissions and intensive care admissions from COVID-19. Anaesthesia 76(5):608-616. |
|
|
ECDC - European Centre for Disease Prevention and Control (2021). COVID-19 Surveillance Report. |
|
|
Fresán U, Guevara M, Elía F, Albéniz E, Burgui C, Castilla J, Martín C, Navascués A, Portillo ME, Polo I, Ezpeleta C, Albéniz E, Elía F, Gorricho J, Ardanaz E, Ascunce N, Arriazu M, Barricarte A, Barriuso L, Castilla J (2021). Independent Role of Severe Obesity as a Risk Factor for COVID-19 Hospitalization: A Spanish Population-Based Cohort Study. Obesity 29(1):29-37. |
|
|
Ge E, Li Y, Wu S, Candido E, Wei X (2021). Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. PLoS ONE 16(10):1-18. |
|
|
Guo L, Shi Z, Zhang Y, Wang C, Cristina N, Vale D (2020). Comorbid diabetes and the risk of disease severitytrun or death among 8807 COVID-19 patients in China: A meta-analysis Li. Diabetes Research and Clinical Practice Journal 166(January):108346. |
|
|
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z (2020). Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiology 5(7):811-818. |
|
|
Inciarte A, Gonzalez-Cordon A, Rojas J, Torres B, de Lazzari E, de la Mora L, Martinez-Rebollar M, Laguno M, Callau P, Gonzalez-Navarro A, Leal L, Garcia F, Mallolas J, Mosquera M, Marcos MA, Ambrosioni J, Miro JM, Martinez E, Blanco JL (2020). Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study. AIDS (London, England) 34(12):1775-1780. |
|
|
Jere KC, Hungerford D, Bar-zeev N, Kanjerwa O, Houpt ER, Operario DJ, Wachepa R, Health G, Building RR (2000). Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons with Breakthrough SARS-CoV-2 Infection in a High-risk National Population, pp. 1-41. |
|
|
Liz Essley Whyte CZS (2020). Underlying Health Disparities Could Mean Coronavirus Hits Some Communities Harder. |
|
|
Lopez BJ, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G, Myers R, Campbell CNJ, Amirthalingam G, Edmunds M, Zambon M, Brown KE, Hopkins S, Chand M, Ramsay M (2021). Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. New England Journal of Medicine 385(7):585-594. |
|
|
Medina C, Cornejo E, Morello E (2020). Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One 15(12):1-12. |
|
|
MoH-Kenya (2015). Kenya STEPwise Survey for Non Communicable Diseases Risk Factors 2015 Report. Public Health 5(7):8-210. |
|
|
MoH (2021). Coronavirus - Kenya: Covid-19 Vaccination (26 July 2021). |
|
|
Mondor L, Cohen D, Khan AI, Wodchis WP (2018). Income inequalities in multimorbidity prevalence in Ontario, Canada: A decomposition analysis of linked survey and health administrative data. International Journal for Equity in Health 17(1):1-13. |
|
|
Mwangi I (2021). Kenya Surpasses 10 Million Target In COVID-19 Vaccination. Capital News. |
|
|
Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005). Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care 43(11):1130-1139. |
|
|
Rahman A, Tabassum T, Araf Y, Al A, Asad N, Mohammad U, Hosen J (2021). Silent hypoxia in COVID 19: pathomechanism and possible management strategy. Molecular Biology Reports 48:3863-3869. |
|
|
Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, Maclaren G, and Brodie D (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395(10229)(January):19-21. |
|
|
Reddy RK, Charles WN, Sklavouno A, Dutt A, Seed PT, Khajuria A (2021). The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. Journal of Medical Virology 93(2):1045-1056. |
|
|
Rosenberg ES, Dorabawila V, Easton D, Bauer UE, Kumar J, Hoen R, Hoefer D, Wu M, Lutterloh E, Conroy MB, Greene D, Zucker HA (2022). Covid-19 Vaccine Effectiveness in New York State. New England Journal of Medicine 386(2):116-127. |
|
|
Sadeghi A, Eslami P, Moghadam AD, Pirsalehi A, Shojaee S, Vahidi M, Soheili A, Ghanimat F, Keshmiri Y, Abdi S, Zali MR (2020). COVID-19 and ICU admission associated predictive factors in Iranian patients. Caspian Journal of Internal Medicine 11(5):S512-S519. |
|
|
Shaikh FS, Aldhafferi N, Buker A, Alqahtani A, Dey S, Abdulhamid S, Albuhairi D AM, Alkabour RSA, Atiyah WSO, Chrouf SB, Alshehri A, Olatunji SO, Almuhaideb AM, Alshahrani MS, Almunsour Y, Abdul-Salam VB (2021). Comorbidities and risk factors for severe outcomes in covid-19 patients in saudi arabia: A retrospective cohort study. Journal of Multidisciplinary Healthcare 14:2169-2183. |
|
|
Surme S, Buyukyazgan A, Bayramlar OF, Cinar AK, Copur B, Zerdali E, Tuncer G, Balli H, Nakir IY, YazlaM, Kurekci Y, Pehlivanoglu F, Sengoz G (2021). Predictors of intensive care unit admission or mortality in patients with coronavirus disease 2019 pneumonia in istanbul, turkey. Japanese Journal of Infectious Diseases 74(5):458-464. |
|
|
Tesoriero JM, Swain CAE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, Gonzalez CJ, Udo T, Morne JE, Hart-Malloy R, Rajulu DT, Leung SYJ, Rosenberg ES (2021). COVID-19 Outcomes among Persons Living with or without Diagnosed HIV Infection in New York State. JAMA Network Open 4(2):1-14. |
|
|
Tessema SK, Nkengasong JN (2021). Understanding COVID-19 in Africa. Nature Reviews Immunology 21(8):469-470. |
|
|
Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, DeSilva MB, Natarajan K, Bozio CH, Lewis N, Dascomb K, Dixon BE, Birch R J, Irving SA, Rao S, Kharbanda E, Han J, Reynolds S, Goddard K, Klein NP (2021). Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings. New England Journal of Medicine 385(15):1355-1371. |
|
|
Venkatesan P (2020). The changing demographics of COVID-19. In The Lancet. Respiratory Medicine 8(12):e95 |
|
|
Whittaker R, Kristofferson AB, Salamanca BV, and Buanes EA (2022). Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients. Clinical Microbiology and Infection 28(6):871-878. |
|
|
WHO (2020a). Coronavirus disease (COVID-19): HIV and antiretrovirals. |
|
|
WHO (2020b). Covid-19 Case Investigation Form. |
|
|
WHO (2021). Coronavirus Disease 2019 Situation Report - 46. Clinics in Geriatric Medicine 37(4):509-522. |
|
|
WHO (2022a). Coronavirus (COVID-19) statistics. |
|
|
WHO (2022b). ICD-11 Coding Tool. |
|
|
WHO (2021). Coronavirus disease (COVID-19). |
|
|
Yadav AK, Sankarasubbaiyan S, Gowda BG, Shah K, Jha V (2021). The High Mortality and Impact of Vaccination on COVID-19 in Hemodialysis Population in India During the Second Wave. Kidney International Reports 6(10):2731. |
|
|
Yek C, Warner S, Wiltz JL, Sun J, Adjei S, Mancera A, Silk BJ, Gundlapalli AV, Harris AM, Boehmer TK, Kadri SS (2022). Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series - 465 Health Care Facilities, United States, December 2020-October 2021. MMWR. Morbidity and Mortality Weekly Report 71(1):19-25. |
|
|
Zhang Z, Zhang H, Khanal MK (2017). Development of scoring system for risk stratification in clinical medicine: a step-by-step tutorial. Annals of Translational Medicine 5(21). |
|
|
Zhou Y, Yang Q, Chi J, Dong B, Lv W, Shen L (2020). Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. International Journal of Infectious Diseases, January. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
